![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MAN2B2 |
Gene summary for MAN2B2 |
![]() |
Gene information | Species | Human | Gene symbol | MAN2B2 | Gene ID | 23324 |
Gene name | mannosidase alpha class 2B member 2 | |
Gene Alias | MAN2B2 | |
Cytomap | 4p16.1 | |
Gene Type | protein-coding | GO ID | GO:0005975 | UniProtAcc | B7Z754 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23324 | MAN2B2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 5.38e-43 | 8.95e-01 | 0.0155 |
23324 | MAN2B2 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.91e-29 | 9.31e-01 | -0.1808 |
23324 | MAN2B2 | HTA11_2951_2000001011 | Human | Colorectum | AD | 2.80e-10 | 9.09e-01 | 0.0216 |
23324 | MAN2B2 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.86e-39 | 1.56e+00 | -0.0811 |
23324 | MAN2B2 | HTA11_78_2000001011 | Human | Colorectum | AD | 1.79e-07 | 4.05e-01 | -0.1088 |
23324 | MAN2B2 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.07e-34 | 8.50e-01 | -0.1954 |
23324 | MAN2B2 | HTA11_411_2000001011 | Human | Colorectum | SER | 3.97e-16 | 1.35e+00 | -0.2602 |
23324 | MAN2B2 | HTA11_2112_2000001011 | Human | Colorectum | SER | 2.41e-17 | 1.47e+00 | -0.2196 |
23324 | MAN2B2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.77e-27 | 9.58e-01 | -0.1207 |
23324 | MAN2B2 | HTA11_83_2000001011 | Human | Colorectum | SER | 8.63e-35 | 1.36e+00 | -0.1526 |
23324 | MAN2B2 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.51e-94 | 1.66e+00 | -0.1464 |
23324 | MAN2B2 | HTA11_866_2000001011 | Human | Colorectum | AD | 9.19e-42 | 9.01e-01 | -0.1001 |
23324 | MAN2B2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.76e-54 | 1.40e+00 | -0.059 |
23324 | MAN2B2 | HTA11_2992_2000001011 | Human | Colorectum | SER | 8.04e-23 | 1.13e+00 | -0.1706 |
23324 | MAN2B2 | HTA11_5212_2000001011 | Human | Colorectum | AD | 3.44e-25 | 1.30e+00 | -0.2061 |
23324 | MAN2B2 | HTA11_5216_2000001011 | Human | Colorectum | SER | 3.59e-25 | 1.44e+00 | -0.1462 |
23324 | MAN2B2 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.41e-15 | 7.96e-01 | -0.0842 |
23324 | MAN2B2 | HTA11_9341_2000001011 | Human | Colorectum | SER | 6.47e-03 | 6.44e-01 | -0.00410000000000005 |
23324 | MAN2B2 | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.24e-07 | 4.82e-01 | -0.0179 |
23324 | MAN2B2 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.25e-15 | 5.37e-01 | 0.096 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0019318 | Colorectum | AD | hexose metabolic process | 77/3918 | 237/18723 | 1.96e-05 | 4.01e-04 | 77 |
GO:0005996 | Colorectum | AD | monosaccharide metabolic process | 80/3918 | 257/18723 | 7.31e-05 | 1.17e-03 | 80 |
GO:00193181 | Colorectum | SER | hexose metabolic process | 56/2897 | 237/18723 | 6.19e-04 | 8.42e-03 | 56 |
GO:00059961 | Colorectum | SER | monosaccharide metabolic process | 59/2897 | 257/18723 | 9.65e-04 | 1.15e-02 | 59 |
GO:00193182 | Colorectum | MSS | hexose metabolic process | 63/3467 | 237/18723 | 1.32e-03 | 1.25e-02 | 63 |
GO:00059962 | Colorectum | MSS | monosaccharide metabolic process | 66/3467 | 257/18723 | 2.61e-03 | 2.06e-02 | 66 |
GO:00059969 | Esophagus | ESCC | monosaccharide metabolic process | 159/8552 | 257/18723 | 1.11e-07 | 1.81e-06 | 159 |
GO:00193189 | Esophagus | ESCC | hexose metabolic process | 147/8552 | 237/18723 | 2.63e-07 | 3.94e-06 | 147 |
GO:000599621 | Liver | HCC | monosaccharide metabolic process | 167/7958 | 257/18723 | 2.31e-13 | 1.25e-11 | 167 |
GO:001931821 | Liver | HCC | hexose metabolic process | 155/7958 | 237/18723 | 7.63e-13 | 3.90e-11 | 155 |
GO:001931810 | Thyroid | PTC | hexose metabolic process | 108/5968 | 237/18723 | 6.42e-06 | 7.65e-05 | 108 |
GO:000599614 | Thyroid | PTC | monosaccharide metabolic process | 115/5968 | 257/18723 | 9.36e-06 | 1.05e-04 | 115 |
GO:001931814 | Thyroid | ATC | hexose metabolic process | 111/6293 | 237/18723 | 1.51e-05 | 1.41e-04 | 111 |
GO:000599615 | Thyroid | ATC | monosaccharide metabolic process | 118/6293 | 257/18723 | 2.56e-05 | 2.20e-04 | 118 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa00511 | Liver | HCC | Other glycan degradation | 15/4020 | 18/8465 | 1.96e-03 | 6.91e-03 | 3.84e-03 | 15 |
hsa005111 | Liver | HCC | Other glycan degradation | 15/4020 | 18/8465 | 1.96e-03 | 6.91e-03 | 3.84e-03 | 15 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MAN2B2 | SNV | Missense_Mutation | rs140604370 | c.2063N>T | p.Pro688Leu | p.P688L | Q9Y2E5 | protein_coding | deleterious(0) | possibly_damaging(0.774) | TCGA-66-2786-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MAN2B2 | SNV | Missense_Mutation | novel | c.1520N>C | p.Gly507Ala | p.G507A | Q9Y2E5 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-92-8064-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD |
MAN2B2 | SNV | Missense_Mutation | novel | c.839C>A | p.Pro280Gln | p.P280Q | Q9Y2E5 | protein_coding | tolerated(0.26) | benign(0.132) | TCGA-CV-7242-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MAN2B2 | SNV | Missense_Mutation | rs377039829 | c.2041N>T | p.Arg681Cys | p.R681C | Q9Y2E5 | protein_coding | deleterious(0.01) | possibly_damaging(0.677) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MAN2B2 | SNV | Missense_Mutation | rs151180999 | c.1834N>T | p.Arg612Cys | p.R612C | Q9Y2E5 | protein_coding | deleterious(0.04) | possibly_damaging(0.873) | TCGA-EJ-7782-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 8 | Unknown | Unknown | SD |
MAN2B2 | SNV | Missense_Mutation | rs138386873 | c.1394C>T | p.Ala465Val | p.A465V | Q9Y2E5 | protein_coding | tolerated(0.56) | benign(0) | TCGA-YL-A8SI-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Hormone Therapy | eligard | SD |
MAN2B2 | SNV | Missense_Mutation | rs778596906 | c.2551N>A | p.Gly851Arg | p.G851R | Q9Y2E5 | protein_coding | tolerated(0.81) | benign(0.015) | TCGA-B7-5816-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MAN2B2 | SNV | Missense_Mutation | rs540480695 | c.2605N>A | p.Val869Met | p.V869M | Q9Y2E5 | protein_coding | deleterious(0.03) | probably_damaging(0.956) | TCGA-B7-A5TI-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | eloxatin | CR |
MAN2B2 | SNV | Missense_Mutation | rs768266831 | c.430N>T | p.Pro144Ser | p.P144S | Q9Y2E5 | protein_coding | deleterious(0.03) | probably_damaging(0.936) | TCGA-BR-4368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MAN2B2 | SNV | Missense_Mutation | rs553296276 | c.476C>T | p.Thr159Met | p.T159M | Q9Y2E5 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BR-4370-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |